Rich Habits on $IBB (Nov 16, 2026)
IBB is another interesting one: biotech sits at a singularity point for AI's positive impact on research, and with petabytes of data now available, the speaker sees the early innings of a potentially massive singularity event for healthcare in America and globally, starting with biotech names.
Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy
Jump to any passage
There's also IBB, which is the EyesShares biotechnology ETF that exists out there. I think biotech is at its like singularity when it comes to how artificial intelligence can positively impact the research done.
I think now 3 4 years now since chat GBT came out the the pabytes of data that exist that can you know positively impact research and biotechnology companies I think we are at the early innings of what a massive singularity event could be for healthcare in America and all around the world and I think it starts with these biotechnology names so IBB is another interesting one